Since this facility produces around 25% of Pfizer’s sterile injectable products for U.S. hospitals, this may mean yet more product shortages in this country.
Since this facility produces around 25% of Pfizer’s sterile injectable products for U.S. hospitals, this may mean yet more product shortages in this country.